睿昂基因 (688217)
Shanghai Rightongene Biotechnology Co., Ltd.
K-Line Chart
No K-line data available
Company NameShanghai RuiAng Gene Technology Co., Ltd.
Listing Date2021-05-17
Issue Price18.42RMB
Registered Capital5585.589610k RMB
Legal RepresentativeGao Shangxian
Registered AddressBuilding 3, No. 6055 Jinhai Highway, Fengxian District, Shanghai
IndustryMedical Devices
Main BusinessResearch and development, production, sales, and scientific research services of in vitro diagnostic products. Primarily provides molecular precision testing for patients with hematological diseases (leukemia, lymphoma), solid tumors (lung cancer, colorectal cancer, melanoma, etc.), and infectious diseases (hepatitis B, rubella, herpes simplex, etc.), offering a basis for formulating personalized treatment plans such as risk assessment, disease typing, targeted drug selection, and efficacy monitoring. Simultaneously, actively expanding into antigen detection reagent products for immunodiagnostics.
Company ProfileShanghai RuiAng Gene Technology Co., Ltd. has established three nucleic acid molecular diagnostic reagent production lines certified by the National Medical Products Administration (NMPA, formerly CFDA) and a research and development laboratory with top-tier talent and equipment, along with standardized internal management systems. Currently, the company possesses NMPA-certified in vitro diagnostic reagent production facilities and systems in Shanghai, Suzhou, and Wuhan. As of 2019, it has obtained 28 Class III medical device registration certificates and 14 Class I medical device registration certificates, with over 50 more in preparation for application. Among these, the leukemia-related fusion gene detection kit and the UGT1A1 genotype detection kit are the first products approved for marketing in China.
Stock Details
1. Key Indicators
- Total Shares(W): 5585.59
- Circulating A-Shares(W): 5585.59
- Earnings Per Share(RMB): -0.1000
- Net Assets Per Share(RMB): 16.1780
- Operating Revenue(W RMB): 13910.36
- Total Profit(W RMB): -1651.29
- **Net Profit Attributable to Parent(W RMB) **: -562.07
- Net Profit Growth Rate(%): -198.14
- Weighted Return on Equity(%): -0.6200
- Operating Cash Flow Per Share(RMB): 0.4810
- Undistributed Profit Per Share(RMB): 2.3483
- Capital Reserve Per Share(RMB): 13.1080
2. Main Business
The main business covers:
- Research, development, production, and sales of in vitro diagnostic products (including testing instruments and reagents)
- Scientific research and testing services
3. Company Basic Information
- Company Name: RuiAng Gene
- Listing Date: Unknown
- Industry: Unknown
- Address: Unknown
- Website: Unknown
- Company Profile: None
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| Data Not Available | Data Not Available | Data Not Available | Data Not Available | Data Not Available |
5. Concept Sectors
- Gene Concept
- Artificial Intelligence
- Data Elements
- Margin Trading
- Micro-Cap Stocks
- Consecutive Losses
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information